ResMed Q1 FY27: where the revenue came from and where it went
The whole income statement of ResMed for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2026
Revenue$1.42B
+6% year over year
Gross profit$0.87B
62% margin
Operating profit$0.45B
32% margin
Net profit$0.42B
30% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 1.42 | 100% | +6% |
| Cost of revenue | −0.54 | 38% | |
| Gross profit | 0.87 | 62% margin | |
| R&D | −0.10 | 8% | +1pp |
| SG&A | −0.32 | 22% | |
| Operating profit | 0.45 | 32% margin | −1pp |
| Other income, net | 0.09 | ||
| Tax | −0.12 | ||
| Net profit | 0.42 | 30% margin | +3pp |
148 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest